Table 3. ctDNA status based on ethnicity and number of metastatic sites for all plasma samples.
Ethnicity | Stage | No. Met. Sites | ctDNA | ||||
---|---|---|---|---|---|---|---|
Positive | Negative | ||||||
N | % | N | % | ||||
Caucasian | I-III | 0 | 19 | 19 | 79 | 81 | |
IV | 1 | 12 | 36 | 21 | 64 | ||
>1 | 5 | 50 | 5 | 50 | |||
Asian | I-III | 0 | 11 | 26 | 32 | 74 | |
IV | 1 | 5 | 56 | 4 | 44 | ||
>1 | 1 | 50 | 1 | 50 | |||
Hispanic | I-III | 0 | 5 | 19 | 21 | 81 | |
IV | 1 | 0 | 0 | 5 | 100 | ||
>1 | 1 | 100 | 0 | 0 | |||
AA | I-III | 0 | 4 | 31 | 9 | 69 | |
IV | 1 | 0 | 0 | 1 | 100 | ||
>1 | 4 | 100 | 0 | 0 |
No. Met. Sites, number of metastatic sites; AA, African American.